Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab
Loading...
Date
2018-09
Journal Title
Journal ISSN
Volume Title
Publisher
All India Ophthalmological Society
Abstract
Idiopathic intracranial hypertension (IIH) is a common cause of papilledema in young females and causes headache with transient visual loss. Severe visual loss occurs due to optic atrophy or peripapillary choroidal neovascular membrane (PCNVM). PCNVM in IIH has an incidence of 0.5% with a benign course in the majority of patients. Intravitreal Anti-vascular endothelial growth factor agents have anecdotally been used to manage these patients, with complete resolution reported in all cases after a single injection. Our case of IIH-associated PCNVM was treated with three injections of intravitreal ranibizumab with no recurrence at 6-month follow-up.
Description
Keywords
Idiopathic intracranial hypertension, intravitreal ranibizumab, peripapillary choroidal neovascular membrane
Citation
Kumar N, Tigari B, Dogra M, Singh R. Successful management of peripapillary choroidal neovascular membrane secondary to idiopathic intracranial hypertension with intravitreal ranibizumab. Indian Journal of Ophthalmology. 2018 Sep; 66(9): 1358-1360